These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18201137

  • 1. Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection.
    Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Atwal E, Rübsamen-Waigmann H, Kleymann G.
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):34-42. PubMed ID: 18201137
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S, Miyazaki D, Haruki T, Yamamoto Y, Kandori M, Yakura K, Suzuki H, Inoue Y.
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [Abstract] [Full Text] [Related]

  • 3. Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
    Baumeister J, Fischer R, Eckenberg P, Henninger K, Ruebsamen-Waigmann H, Kleymann G.
    Antivir Chem Chemother; 2007 Apr; 18(1):35-48. PubMed ID: 17354650
    [Abstract] [Full Text] [Related]

  • 4. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.
    Betz UA, Fischer R, Kleymann G, Hendrix M, Rübsamen-Waigmann H.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1766-72. PubMed ID: 12019088
    [Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ, Grygon CA, Hargrave KD, Simoneau B, Faucher AM, Bolger G, Kibler P, Liuzzi M, Cordingley MG.
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA, Frost AL, Itzhaki RF.
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.
    Perng GC, Maguen B, Jin L, Mott KR, Osorio N, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, Inman M, Henderson G, Jones C, Wechsler SL.
    J Virol; 2002 Feb; 76(3):1224-35. PubMed ID: 11773398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.